8 Dec 2020 18:02
LiDCO Group Plc
("LiDCO" or the "Company")
Notice of Cancellation
LiDCO (AIM: LID), a leading supplier of hemodynamic monitoring solutions, announces that it has applied to the London Stock Exchange for the cancellation of the admission of the Company's shares to trading on AIM.
This follows the announcement released earlier today, where the recommended cash offer made by Masimo LHC Limited ("Masimo") for the entire issued and to be issued share capital of LiDCO ("Offer") was declared wholly unconditional in all respects. Masimo requested that the LiDCO Board takes the necessary steps to apply to the London Stock Exchange for the cancellation of the admission to trading of LiDCO Shares on AIM and to re-register LiDCO as a private limited company under the relevant provisions of the Companies Act.
Accordingly, admission of the Company's shares to trading on AIM will be cancelled with effect from 7.00 a.m. on 11 January 2021. The last day of dealings in the Company's shares on AIM will be 8 January 2021 following which shareholders who have not accepted the Offer will not be able to trade their shares on a public trading platform.
Following cancellation, N+1 Singer will cease to act as nominated adviser and broker to the Company.
Masimo have extended the Offer which will now remain open for acceptances until 1.00pm on 11 January 2021.
For further information:
LiDCO Peter Grant (Non-Executive Chairman) Matt Sassone (Chief Executive Officer) Tim Hall (Chief Financial Officer)
| Tel: +44 20 7749 1500 |
N+1 Singer - Nominated Adviser and Broker to LiDCO Aubrey Powell George Tzimas | Tel: +44 20 7496 3600 |
|
|
|
|